MISSD founder, Wendy Dolin, and board advisor, Kim Witczak, were pleased to join a coalition of consumer safety advocates from various public health organizations who spoke to the Food and Drug Administration (FDA) last week. The coalition encouraged the FDA to improve the Accelerated Approval program by requiring confirmatory trials be started prior to granting accelerated approval. Safe patient advocates also alerted the FDA of the need to regulate lab-developed tests to ensure their accuracy and asked that the agency make improvements to its Advisory Committee process.